Author

Mikhail Reibarkh

Merck & Co., Inc., Rahway, NJ, USA (United States)ORCID 0000-0002-6589-707XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Biochemistry· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:deep learning· 1 Research Focus:drug response / drug discovery· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

Anna LewickaiD· 1 shared Anne CooperiD· 1 shared Chang Qi· 1 shared Chenguang YuiD· 1 shared Erik D. HolmstromiD· 1 shared Jingxin WangiD· 1 shared Joseph A. PiccirilliiD· 1 shared K.P. BattaileiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBiochemistry

Anna LewickaORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Mechanistic Studies of Small Molecule Ligands Selective to RNA Single G Bulges

Shalakha Hegde, Sana Akhter, Zhichao Tang, Chang Qi, Chenguang Yu, Anna Lewicka, Yu Liu, Kushal Koirala, Mikhail Reibarkh, K.P. Battaile, Anne Cooper, S. Lovell, Erik D. Holmstrom, Xiao Wang, Joseph A. Piccirilli, , Jingxin Wang

This study identifies coumarin derivatives that selectively bind RNA single G bulges, revealing key structural features and using computational and experimental methods to guide rational ligand design.

Nucleic Acids Research · Jun 5, 2025Peer-reviewedBiochemistry